Randomized trial of locally advanced prostate cancer. Antiandrogen treatment with or without radiotherapy
Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Sed posuere consectetur est at lobortis. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Maecenas faucibus mollis interdum.
Publications of the SPCG-7/FUO3 trial
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
Widmark A, Fosså SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.
Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A
Lancet Oncol. 2009
Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA
J Urol. 2010
Validation of the intestinal part of the prostate cancer questionnaire ”QUFW94”: psychometric properties, responsiveness, and content validity
Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fosså SD, Kaasa S
Int J Radiat Oncol Biol Phys. 2010